References
- Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007;83:1069–74.
- Van Gelder F, Delbouille MH, Vandervennet M, Van Beeumen G, Van Deynse D, Angenon E, An 11-year overview of the Belgian donor and transplant statistics based on a consecutive yearly data follow-up and comparing two periods: 1997 to 2005 versus 2006 to 2007. Transplant Proc 2009;41:569–71.
- Burmeister D, Noster M, Kram W, Kundt G, Seiter H. [Urological complications after kidney transplantation]. Urologe A 2006;45:25–31.
- Reinberg Y, Manivel JC, Sidi AA, Ercole CJ. Transurethral resection of prostate immediately after renal transplantation. Urology 1992;39:319–21.
- Koziolek MJ, Wolfram M, Muller GA, Scheel AK, Strutz F, Scheuermann EH, Benign prostatic hyperplasia (BPH) requiring transurethral resection in freshly transplanted renal allograft recipients. Clin Nephrol 2004;62:8–13.
- Tsaur I, Jones J, Melamed RJ, Blaheta RA, Gossmann J, Bentas W. Postoperative voiding dysfunction in older male renal transplant recipients. Transplant Proc 2009;41:1615–18.
- Hurst FP, Neff RT, Falta EM, Jindal RM, Lentine KL, Swanson JS, Incidence, predictors, and associated outcomes of prostatism after kidney transplantation. Clin J Am Soc Nephrol 2009;4:329–36.
- Shoskes DA, Hanbury D, Cranston D, Morris PJ. Urological complications in 1,000 consecutive renal transplant recipients. J Urol 1995;153:18–21.
- Sarma AV, Jaffe CA, Schottenfeld D, Dunn R, Montie JE, Cooney KA, Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among black men. Urology 2002;59:362–7.
- Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 2002;52:98–105.
- Dahle SE, Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Hsing AW. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002;168:599–604.
- Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001;39:151–8.
- Nandeesha H, Koner BC, Dorairajan LN, Sen SK. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta 2006;370:89–93.
- Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 2007;178:395–401.
- Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 2006;91:2562–8.
- Zucchetto A, Tavani A, Dal Maso L, Gallus S, Negri E, Talamini R, History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes (Lond) 2005;29:798–803.
- Hong J, Kwon S, Yoon H, Lee H, Lee B, Kim HH, Risk factors for benign prostatic hyperplasia in South Korean men. Urol Int 2006;76:11–19.
- Zhu YS, Imperato-McGinley JL. 5alpha-reductase isozymes and androgen actions in the prostate. Ann N Y Acad Sci 2009;1155:43–56.
- Spark RF. Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep 2007;8:467–71.
- Gupta A, Ketchum N, Roehrborn CG, Schecter A, Aragaki CC, Michalek JE. Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Environ Health Perspect 2006;114:1649–54.
- Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000;23:912–18.
- Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 1998;9:3–9.
- Abou-Seif MA, Youssef AA. Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin Chem Lab Med 2001;39:618–23.